416
Participants
Start Date
August 31, 2008
Primary Completion Date
May 31, 2009
BI 44370 TA Low Dose
Eletriptan
Placebo
BI 44370 TA Medium Dose
1246.4.32004 Boehringer Ingelheim Investigational Site, Antwerp
1246.4.32005 Boehringer Ingelheim Investigational Site, Brussels
1246.4.32006 Boehringer Ingelheim Investigational Site, Charleroi
1246.4.32001 Boehringer Ingelheim Investigational Site, Ghent
1246.4.32002 Boehringer Ingelheim Investigational Site, Hasselt
1246.4.32009 Boehringer Ingelheim Investigational Site, Leuven
1246.4.32007 Boehringer Ingelheim Investigational Site, Liège
1246.4.32008 Boehringer Ingelheim Investigational Site, Montegnée
1246.4.34004 Boehringer Ingelheim Investigational Site, Oviedo
1246.4.3307A Boehringer Ingelheim Investigational Site, Clermont-Ferrand
1246.4.3307B Boehringer Ingelheim Investigational Site, Clermont-Ferrand
1246.4.3303A Boehringer Ingelheim Investigational Site, Lille
1246.4.3301A Boehringer Ingelheim Investigational Site, Nice
1246.4.3301B Boehringer Ingelheim Investigational Site, Nice
1246.4.3305B Boehringer Ingelheim Investigational Site, Paris
1246.4.3304A Boehringer Ingelheim Investigational Site, Rouen
1246.4.3304B Boehringer Ingelheim Investigational Site, Rouen
1246.4.3302A Boehringer Ingelheim Investigational Site, Toulouse
1246.4.3302B Boehringer Ingelheim Investigational Site, Toulouse
1246.4.49002 Boehringer Ingelheim Investigational Site, Berlin
1246.4.49003 Boehringer Ingelheim Investigational Site, Erkelenz
1246.4.49001 Boehringer Ingelheim Investigational Site, Essen
1246.4.49006 Boehringer Ingelheim Investigational Site, Göttingen
1246.4.49004 Boehringer Ingelheim Investigational Site, Grevenbroich
1246.4.49011 Boehringer Ingelheim Investigational Site, Hüttenberg
1246.4.49007 Boehringer Ingelheim Investigational Site, Koenigstein Im Taurus
1246.4.49008 Boehringer Ingelheim Investigational Site, Munich
1246.4.49009 Boehringer Ingelheim Investigational Site, Munich
1246.4.49010 Boehringer Ingelheim Investigational Site, Münster
1246.4.39005 Boehringer Ingelheim Investigational Site, Bologna
1246.4.39006 Boehringer Ingelheim Investigational Site, Catania
1246.4.39001 Boehringer Ingelheim Investigational Site, Milan
1246.4.39004 Boehringer Ingelheim Investigational Site, Milan
1246.4.39003 Boehringer Ingelheim Investigational Site, Roma
1246.4.39002 Boehringer Ingelheim Investigational Site, Torino
1246.4.31001 Boehringer Ingelheim Investigational Site, 's-Hertogenbosch
1246.4.31004 Boehringer Ingelheim Investigational Site, Amsterdam
1246.4.31003 Boehringer Ingelheim Investigational Site, Blaricum
1246.4.31002 Boehringer Ingelheim Investigational Site, Breda
1246.4.31005 Boehringer Ingelheim Investigational Site, Nijmegen
1246.4.31006 Boehringer Ingelheim Investigational Site, Zwolle
1246.4.34002 Boehringer Ingelheim Investigational Site, Barcelona
1246.4.34005 Boehringer Ingelheim Investigational Site, Santiago de Compostela
1246.4.34001 Boehringer Ingelheim Investigational Site, Valencia
1246.4.46001 Boehringer Ingelheim Investigational Site, Gothenburg
1246.4.46004 Boehringer Ingelheim Investigational Site, Linköping
1246.4.46005 Boehringer Ingelheim Investigational Site, Stockholm
1246.4.46002 Boehringer Ingelheim Investigational Site, Vällingby
1246.4.44013 Boehringer Ingelheim Investigational Site, Liverpool
1246.4.44001 Boehringer Ingelheim Investigational Site, Oxford
1246.4.44003 Boehringer Ingelheim Investigational Site, Plymouth
1246.4.44007 Boehringer Ingelheim Investigational Site, Whitechapel, London
Lead Sponsor
Boehringer Ingelheim
INDUSTRY